Australian Dry Eye

Click here to edit subtitle


New Dry Eye Web Store Coming Soon!

Posted by australiandryeye on June 9, 2017 at 12:20 AM Comments comments (1)

AustralianDryEye is currently in the process of developing new webstore to retail products specifically for the needs of dry eye patients.

Stayed tuned for updates.

Lacritin - Keynote Presentation this Month!

Posted by No More Tears on September 15, 2013 at 2:20 AM Comments comments (1)

Several Lacritin presentations were held at the Tear Film and Ocular Surface Society meeting in Taormina Sicily (September 18 - 21st), including a keynote presentation from Consortium member Andrew Mackay.

Andrew reported on how linkage of Lacritin to an elastin-like peptide creates a gel for slow release from the surface of the eye. The Laurie Lab presented new data on how Lacritin protects corneal epithelial cells against inflammatory cytokines that are elevated in Dry Eye.

Further Information:


TFOS Schedule

Welcome to Australian Dry Eye

Posted by No More Tears on June 16, 2013 at 11:10 PM Comments comments (0)

Thank you to all those ECP's who responded to our message, and have supported our call for better care of Dry Eye Patients in Australia.

We have the following update for all Australian Dry Eye sufferers:

- Our Open Letter has been recommended for Publication, and we hope to keep raising awareness for this condition via as many health publications and media outlets as possible.

- Dr. Jim Kokkinakis from The Eye Practice in Sydney has been a great support to our cause and runs an informative blog about Dry Eye. 

- Please refer to our 'Find a Doc' tab if your symptoms continue to worsen. These doctors have an personal interest in Dry Eye and will help you understand the condition as well as offer better treatment options and sympathy.

 - There is a new treatment that is now available in Australia known as 'Optimel™'. It is indicated for use in chronic (long-standing) ocular surface diseases: eye lid margin disease (blepharitis, meibomitis, meibomian gland disease), aqueous tear deficient dry eye and recurrent corneal erosion. It is a preservative free ointment made from Manuka Honey. Research show the low pH of the honey used in Optimel™ creates an antibacterial environment while it is suspected that the high osmotic pressure due to the honey sugars plays a role to help to clear the ducts of the Meibomian glands. You can find more information about Optimel™ here.

- Research being conducted into better Dry Eye treatments around the world are numerous and promising. Our 'Research' tab lists the latest and most promising drugs in development to help combat this disease. As we know, Restasis (Cyclosporine) is the only FDA approved treatment to increase tear production, and is only available in Australia with a Special Access Scheme with the TGA , yet there are many reported cases of side effects and it isn't effective in everyone.  New, more advanced options are in development and we want to see these therapeutic options reach the market sooner, rather than later.